Lacosamide and sodium channel‐blocking antiepileptic drug cross‐titration against levetiracetam background therapy

OBJECTIVE: To assess prospectively the effectiveness of lacosamide (LCM) added to levetiracetam (LEV) after down‐titration of a concomitant sodium channel blocker (SCB) among patients with focal epilepsy not adequately controlled on LEV and SCB. METHODS: In this open‐label trial, LCM was initiated a...

Descripción completa

Detalles Bibliográficos
Autores principales: Baulac, M., Byrnes, W., Williams, P., Borghs, S., Webster, E., De Backer, M., Dedeken, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347878/
https://www.ncbi.nlm.nih.gov/pubmed/27714769
http://dx.doi.org/10.1111/ane.12691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347878/
https://www.ncbi.nlm.nih.gov/pubmed/27714769
http://dx.doi.org/10.1111/ane.12691

Ejemplares similares